USPTO serial 88320219
CHANGING THE WORLD BILLIONS OF CELLS ATA TIME
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Mar 29, 2022
- Examiner
- PATEL, SAMIR RAMESH
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with CHANGING THE WORLD BILLIONS OF CELLS ATA TIME?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
KIADIS PHARMA INTELLECTUAL PROPERTY B.V.
AMSTERDAM, NL
Other trademarks owned by KIADIS PHARMA INTELLECTUAL PROPERTY B.V.
KIADIS PHARMA INTELLECTUAL PROPERTY B.V.
AMSTERDAM, NL
Other trademarks owned by KIADIS PHARMA INTELLECTUAL PROPERTY B.V.
KIADIS PHARMA NETHERLANDS B.V.
AMSTERDAM, NL
Dallas, TX
Dallas, TX
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 042 | Scientific and technological services, namely, scientific research, design, analysis and testing in the field of cancer evolution and new cancer therapies using natural killer cells; industrial research in the field of new pharmaceutical products and new cancer therapies; medical and veterinary research services in the nature of the manipulation of cells within a laboratory or research facility to enable natural killer cells to be used for medical or therapeutic purposes; scientific research in the development of new cancer therapies; scientific research in human and animal cell therapy; scientific research into preparations for manipulating and adapting human and animal cells; consultancy relating to all the aforesaid services; conducting research and clinical trials for others relating to the use and the engineering of natural killer cells and cancer treatment and therapy; medical and scientific research in the field of cancer treatment and diagnosis; data collection for others for research purposes, namely, the collection, testing and research of patient molecular and genomic data; collection and preservation of human and animal dna for research purposes; providing a website featuring health and healthcare information related to cancer research | ACTIVE | — |
| 044 | Medical testing for diagnostic or treatment purposes in the field of cancer research; medical diagnostic testing, monitoring and reporting services; medical evaluation of immuno oncological disorders, cancer, diabetes, respiratory, heart, neurological and auto immune disorders; medical monitoring services; medical diagnostic, prognostic and theranostic screening and testing services; collection and preservation of dna for medical purposes; consulting services in the nature of providing medical information; consulting services in the field of healthcare and cancer diagnoses; providing a website featuring health and healthcare information related to cancer, testing and screening; genetic testing for medical purposes; providing information in the field of cancer prevention, screening, diagnosis and treatment for medical diagnostic and treatment purposes; providing genetics assessments in the nature of genetic counseling; genetic testing for medical diagnostic purposes; genomic testing for medical diagnostic purposes; gene analysis and sequencing and dna analysis and sequencing for medical diagnostic purposes and veterinary diagnostics purposes; gene analysis and sequencing and dna analysis and sequencing for use in cancer diagnosis and treatment | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by KIADIS PHARMA INTELLECTUAL PROPERTY B.V.
- Other trademarks owned by KIADIS PHARMA INTELLECTUAL PROPERTY B.V.
- Other trademarks owned by KIADIS PHARMA NETHERLANDS B.V.
- Other trademarks owned by CytoSen Therapeutics, Inc.
- Other trademarks owned by CytoSen Therapeutics, Inc.
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named CHANGING THE WORLD BILLIONS OF CELLS ATA TIME
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 12, 2025 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| May 17, 2022 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| May 17, 2022 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| May 17, 2022 | EWAF | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | — |
| May 17, 2022 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 17, 2022 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Mar 29, 2022 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Feb 25, 2022 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Feb 24, 2022 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Feb 10, 2022 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Feb 9, 2022 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Feb 9, 2022 | EX5G | SOU EXTENSION 5 GRANTED | — |
| Feb 9, 2022 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Feb 2, 2022 | IUAF | USE AMENDMENT FILED | — |
| Feb 2, 2022 | EXT5 | SOU EXTENSION 5 FILED | — |
| Feb 2, 2022 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Feb 2, 2022 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Aug 5, 2021 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Aug 3, 2021 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Aug 3, 2021 | EXT4 | SOU EXTENSION 4 FILED | — |
| Aug 3, 2021 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Feb 13, 2021 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Feb 11, 2021 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Feb 11, 2021 | EXT3 | SOU EXTENSION 3 FILED | — |
| Feb 11, 2021 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Dec 23, 2020 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Aug 7, 2020 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Aug 5, 2020 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Aug 5, 2020 | EXT2 | SOU EXTENSION 2 FILED | — |
| Aug 5, 2020 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jan 30, 2020 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jan 28, 2020 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Jan 28, 2020 | EXT1 | SOU EXTENSION 1 FILED | — |
| Jan 28, 2020 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Aug 13, 2019 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jun 18, 2019 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jun 18, 2019 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 29, 2019 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| May 10, 2019 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 9, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 20, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 4, 2019 | NWAP | NEW APPLICATION ENTERED | — |